Pharmaceutical companies provide one of the, if not the, most important products to HCPs - the medical advances that make a huge difference to patient outcomes. But bringing new me
The UK pharmaceutical industry is just getting to grips with working under two new approaches to regulating branded medicines spend; the 2019 Voluntary Scheme for Branded Medicines Pricing
We speak to McCann Health to find out how the agency is adapting to a world where healthcare communications are becoming broader and more innovative than ever before.
The ubiquity of digital technology allows pharma reps to communicate with healthcare professionals (HCPs) through their preferred channels, making a positive difference to engagement, relat
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.